DHR

Danaher
D

DHR

Arincen73/100B

Danaher executives and insider trading

Christopher Paul Riley reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Danaher's insiders sold 115,092 shares for 26.11M USD in 9 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
9
Shares sold
115,092
Value sold
26.11M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
4.58M USD
0
1 month
13.38M USD
0
3 months
26.11M USD
0
6 months
26.11M USD
0
1 year
26.11M USD
0
2 years
26.11M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Rainer Blair Senior Advisor6258,25512.74M USD—21 Aug 202646,948
Matthew R. McGrew Executive Vice President5447,13911.11M USD—9 Nov 202630,059
Christopher Bouda Vice President & Chief Accounting Officer—7,5981.78M USD—28 Oct 202613,452
Gregory Milosevich Executive Vice President of Life Sciences Business592,100484.30K USD—9 Nov 202622,367

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
9 Nov 2026Matthew R. McGrewSale17,385235.694.10M USD12,674Form 4
9 Nov 2026Gregory MilosevichSale2,100230.62484.30K USD22,367Form 4
28 Oct 2026Christopher BoudaSale4,345234.541.02M USD9,107Form 4
28 Oct 2026Christopher BoudaSale3,253234.58763.09K USD9,107Form 4
28 Oct 2026Matthew R. McGrewSale14,151235.353.33M USD12,674Form 4
28 Oct 2026Matthew R. McGrewSale15,603236.093.68M USD12,674Form 4
21 Aug 2026Rainer BlairSale11,307217.772.46M USD46,948Form 4
21 Aug 2026Rainer BlairSale39,193218.738.57M USD7,755Form 4
21 Aug 2026Rainer BlairSale7,755219.351.70M USD—Form 4

Common questions about Danaher's executives and insiders

Source: Financial Modeling PrepVerified against SEC filings